The global Biosimilars market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddy's Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA
By Types:
Type I
Type II
By Applications:
Application I
Application II
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Biosimilars Market Size Analysis from 2023 to 2028
1.5.1 Global Biosimilars Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Biosimilars Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Biosimilars Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Biosimilars Industry Impact
Chapter 2 Global Biosimilars Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biosimilars (Volume and Value) by Type
2.1.1 Global Biosimilars Consumption and Market Share by Type (2017-2022)
2.1.2 Global Biosimilars Revenue and Market Share by Type (2017-2022)
2.2 Global Biosimilars (Volume and Value) by Application
2.2.1 Global Biosimilars Consumption and Market Share by Application (2017-2022)
2.2.2 Global Biosimilars Revenue and Market Share by Application (2017-2022)
2.3 Global Biosimilars (Volume and Value) by Regions
2.3.1 Global Biosimilars Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Biosimilars Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biosimilars Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Biosimilars Consumption by Regions (2017-2022)
4.2 North America Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Biosimilars Sales, Consumption, Export, Import (2017-2022)
4.10 South America Biosimilars Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Biosimilars Market Analysis
5.1 North America Biosimilars Consumption and Value Analysis
5.1.1 North America Biosimilars Market Under COVID-19
5.2 North America Biosimilars Consumption Volume by Types
5.3 North America Biosimilars Consumption Structure by Application
5.4 North America Biosimilars Consumption by Top Countries
5.4.1 United States Biosimilars Consumption Volume from 2017 to 2022
5.4.2 Canada Biosimilars Consumption Volume from 2017 to 2022
5.4.3 Mexico Biosimilars Consumption Volume from 2017 to 2022
Chapter 6 East Asia Biosimilars Market Analysis
6.1 East Asia Biosimilars Consumption and Value Analysis
6.1.1 East Asia Biosimilars Market Under COVID-19
6.2 East Asia Biosimilars Consumption Volume by Types
6.3 East Asia Biosimilars Consumption Structure by Application
6.4 East Asia Biosimilars Consumption by Top Countries
6.4.1 China Biosimilars Consumption Volume from 2017 to 2022
6.4.2 Japan Biosimilars Consumption Volume from 2017 to 2022
6.4.3 South Korea Biosimilars Consumption Volume from 2017 to 2022
Chapter 7 Europe Biosimilars Market Analysis
7.1 Europe Biosimilars Consumption and Value Analysis
7.1.1 Europe Biosimilars Market Under COVID-19
7.2 Europe Biosimilars Consumption Volume by Types
7.3 Europe Biosimilars Consumption Structure by Application
7.4 Europe Biosimilars Consumption by Top Countries
7.4.1 Germany Biosimilars Consumption Volume from 2017 to 2022
7.4.2 UK Biosimilars Consumption Volume from 2017 to 2022
7.4.3 France Biosimilars Consumption Volume from 2017 to 2022
7.4.4 Italy Biosimilars Consumption Volume from 2017 to 2022
7.4.5 Russia Biosimilars Consumption Volume from 2017 to 2022
7.4.6 Spain Biosimilars Consumption Volume from 2017 to 2022
7.4.7 Netherlands Biosimilars Consumption Volume from 2017 to 2022
7.4.8 Switzerland Biosimilars Consumption Volume from 2017 to 2022
7.4.9 Poland Biosimilars Consumption Volume from 2017 to 2022
Chapter 8 South Asia Biosimilars Market Analysis
8.1 South Asia Biosimilars Consumption and Value Analysis
8.1.1 South Asia Biosimilars Market Under COVID-19
8.2 South Asia Biosimilars Consumption Volume by Types
8.3 South Asia Biosimilars Consumption Structure by Application
8.4 South Asia Biosimilars Consumption by Top Countries
8.4.1 India Biosimilars Consumption Volume from 2017 to 2022
8.4.2 Pakistan Biosimilars Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Biosimilars Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Biosimilars Market Analysis
9.1 Southeast Asia Biosimilars Consumption and Value Analysis
9.1.1 Southeast Asia Biosimilars Market Under COVID-19
9.2 Southeast Asia Biosimilars Consumption Volume by Types
9.3 Southeast Asia Biosimilars Consumption Structure by Application
9.4 Southeast Asia Biosimilars Consumption by Top Countries
9.4.1 Indonesia Biosimilars Consumption Volume from 2017 to 2022
9.4.2 Thailand Biosimilars Consumption Volume from 2017 to 2022
9.4.3 Singapore Biosimilars Consumption Volume from 2017 to 2022
9.4.4 Malaysia Biosimilars Consumption Volume from 2017 to 2022
9.4.5 Philippines Biosimilars Consumption Volume from 2017 to 2022
9.4.6 Vietnam Biosimilars Consumption Volume from 2017 to 2022
9.4.7 Myanmar Biosimilars Consumption Volume from 2017 to 2022
Chapter 10 Middle East Biosimilars Market Analysis
10.1 Middle East Biosimilars Consumption and Value Analysis
10.1.1 Middle East Biosimilars Market Under COVID-19
10.2 Middle East Biosimilars Consumption Volume by Types
10.3 Middle East Biosimilars Consumption Structure by Application
10.4 Middle East Biosimilars Consumption by Top Countries
10.4.1 Turkey Biosimilars Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Biosimilars Consumption Volume from 2017 to 2022
10.4.3 Iran Biosimilars Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Biosimilars Consumption Volume from 2017 to 2022
10.4.5 Israel Biosimilars Consumption Volume from 2017 to 2022
10.4.6 Iraq Biosimilars Consumption Volume from 2017 to 2022
10.4.7 Qatar Biosimilars Consumption Volume from 2017 to 2022
10.4.8 Kuwait Biosimilars Consumption Volume from 2017 to 2022
10.4.9 Oman Biosimilars Consumption Volume from 2017 to 2022
Chapter 11 Africa Biosimilars Market Analysis
11.1 Africa Biosimilars Consumption and Value Analysis
11.1.1 Africa Biosimilars Market Under COVID-19
11.2 Africa Biosimilars Consumption Volume by Types
11.3 Africa Biosimilars Consumption Structure by Application
11.4 Africa Biosimilars Consumption by Top Countries
11.4.1 Nigeria Biosimilars Consumption Volume from 2017 to 2022
11.4.2 South Africa Biosimilars Consumption Volume from 2017 to 2022
11.4.3 Egypt Biosimilars Consumption Volume from 2017 to 2022
11.4.4 Algeria Biosimilars Consumption Volume from 2017 to 2022
11.4.5 Morocco Biosimilars Consumption Volume from 2017 to 2022
Chapter 12 Oceania Biosimilars Market Analysis
12.1 Oceania Biosimilars Consumption and Value Analysis
12.2 Oceania Biosimilars Consumption Volume by Types
12.3 Oceania Biosimilars Consumption Structure by Application
12.4 Oceania Biosimilars Consumption by Top Countries
12.4.1 Australia Biosimilars Consumption Volume from 2017 to 2022
12.4.2 New Zealand Biosimilars Consumption Volume from 2017 to 2022
Chapter 13 South America Biosimilars Market Analysis
13.1 South America Biosimilars Consumption and Value Analysis
13.1.1 South America Biosimilars Market Under COVID-19
13.2 South America Biosimilars Consumption Volume by Types
13.3 South America Biosimilars Consumption Structure by Application
13.4 South America Biosimilars Consumption Volume by Major Countries
13.4.1 Brazil Biosimilars Consumption Volume from 2017 to 2022
13.4.2 Argentina Biosimilars Consumption Volume from 2017 to 2022
13.4.3 Columbia Biosimilars Consumption Volume from 2017 to 2022
13.4.4 Chile Biosimilars Consumption Volume from 2017 to 2022
13.4.5 Venezuela Biosimilars Consumption Volume from 2017 to 2022
13.4.6 Peru Biosimilars Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Biosimilars Consumption Volume from 2017 to 2022
13.4.8 Ecuador Biosimilars Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Biosimilars Business
14.1 Sandoz International
14.1.1 Sandoz International Company Profile
14.1.2 Sandoz International Biosimilars Product Specification
14.1.3 Sandoz International Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Hospira
14.2.1 Hospira Company Profile
14.2.2 Hospira Biosimilars Product Specification
14.2.3 Hospira Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Teva Pharmaceutical
14.3.1 Teva Pharmaceutical Company Profile
14.3.2 Teva Pharmaceutical Biosimilars Product Specification
14.3.3 Teva Pharmaceutical Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Dr. Reddy's Laboratories
14.4.1 Dr. Reddy's Laboratories Company Profile
14.4.2 Dr. Reddy's Laboratories Biosimilars Product Specification
14.4.3 Dr. Reddy's Laboratories Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Biocon
14.5.1 Biocon Company Profile
14.5.2 Biocon Biosimilars Product Specification
14.5.3 Biocon Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Mylan
14.6.1 Mylan Company Profile
14.6.2 Mylan Biosimilars Product Specification
14.6.3 Mylan Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Amgen
14.7.1 Amgen Company Profile
14.7.2 Amgen Biosimilars Product Specification
14.7.3 Amgen Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Celltrion
14.8.1 Celltrion Company Profile
14.8.2 Celltrion Biosimilars Product Specification
14.8.3 Celltrion Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Roche Diagnostics
14.9.1 Roche Diagnostics Company Profile
14.9.2 Roche Diagnostics Biosimilars Product Specification
14.9.3 Roche Diagnostics Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Merck KGaA
14.10.1 Merck KGaA Company Profile
14.10.2 Merck KGaA Biosimilars Product Specification
14.10.3 Merck KGaA Biosimilars Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Biosimilars Market Forecast (2023-2028)
15.1 Global Biosimilars Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Biosimilars Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Biosimilars Value and Growth Rate Forecast (2023-2028)
15.2 Global Biosimilars Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Biosimilars Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Biosimilars Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Biosimilars Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Biosimilars Consumption Forecast by Type (2023-2028)
15.3.2 Global Biosimilars Revenue Forecast by Type (2023-2028)
15.3.3 Global Biosimilars Price Forecast by Type (2023-2028)
15.4 Global Biosimilars Consumption Volume Forecast by Application (2023-2028)
15.5 Biosimilars Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 2450 |
Date : Jan 2024 |
| Category : Electronics |
Pages : 274 |
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 129 |
| Price : US$ 2450 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 269 |
Request Sample 
Request Discount 
Inquire Before Buy
